In this study, we assessed a panel of 9 serum lipids, encompassing total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and apolipoproteins (Apo) A1, ApoA2, ApoB, ApoC2, and ApoC3, alongside 15 serum bile acids and 6 tumor markers including carcinoembryonic antigen (CEA), carbohydrate antigens (CA) 125, CA19-9, CA242, CA50, and CA72-4. This evidence concerns the gene APOA2 and neoplasm.